🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to assess the relative bioavailability...
Status
Completed
Location
Covance Clinical Research Unit Inc.
Start Date
2020-09-21
Trial ID
NCT04565678
Treatments Being Tested
This is an open-label, multicenter, extension study to evaluate the long-te...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2019-03-21
Trial ID
NCT03853798
Treatments Being Tested
ACTIVATE-KidsT (AG348-C-022) is a multicenter study designed to evaluate th...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Start Date
2022-06-08
Trial ID
NCT05144256
Treatments Being Tested
Study ACTIVATE-Kids (AG348-C-023) will evaluate the efficacy and safety of ...
Status
Active Not Recruiting
Location
Stanford Medicine
Start Date
2022-06-06
Trial ID
NCT05175105
Treatments Being Tested
This is a Phase 1, randomized, single-dose, double-blinded, 4-period, cross...
Status
Completed
Location
PPD Development, LP
Start Date
2020-06-17
Trial ID
NCT04472832
The primary objective of the study is to provide continued access to partic...
Status
Enrolling By Invitation
Location
Hôpital Erasme
Start Date
2023-07-06
Trial ID
NCT05777993
Treatments Being Tested
Part 1 of this study will determine the effect of multiple-dose itraconazol...
Status
Completed
Location
Celerion, Inc
Start Date
2019-06-20
Trial ID
NCT03991312
Treatments Being Tested
The primary purpose of this study is to assess the effect of mitapivat on t...
Status
Completed
Location
Fortrea Clinical Research Unit Inc.
Start Date
2024-10-17
Trial ID
NCT06648824
This is a prospective exploratory multicentre pilot study designed to study...
Status
Not Yet Recruiting
Location
Copenhagen University Hospital - Rigshospitalet
Start Date
2023-12-21
Trial ID
NCT05935202
Treatments Being Tested